Waters Corporation

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2025-06-20 pm EDT			5-day change	1st Jan Change
342.63 ^USD	+0.96%		+0.10%	-7.64%

Jun. 05	Deutsche Bank Adjusts Price Target on Waters to $375 From $395	MT
Jun. 04	Waters Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 08:45 AM

Waters Sees Surge in India Demand as Drugmakers Race to Develop Weight-Loss Drug Generics

Published on 05/15/2025 at 09:14

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Waters Corporation

Deutsche Bank Adjusts Price Target on Waters to $375 From $395	Jun. 05	MT
Waters Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 08:45 AM	Jun. 04
Waters Corp And Units Enters Amendment And Restatement Agreement	May. 29	RE
Waters Corporation Enters into an Amendment and Restatement Agreement in Respect of That Certain Amended and Restated Credit Agreement	May. 29	CI
Waters Corporation acquired Optofluidics, Inc.	May. 21	CI
Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio	May. 21	RE
Waters Acquires Halo Labs	May. 21	MT
Waters Corporation acquired Halo Labs.	May. 20	CI
Waters Sees Surge in India Demand as Drugmakers Race to Develop Weight-Loss Drug Generics	May. 15	MT
Waters Corp's India business boosted by rush for weight-loss drugs	May. 15	RE
UBS Adjusts Price Target on Waters to $360 From $415, Maintains Neutral Rating	May. 07	MT
Barclays Adjusts Price Target on Waters to $360 From $350, Maintains Equalweight Rating	May. 07	MT
Citigroup Adjusts Price Target on Waters to $370 From $390, Maintains Neutral Rating	May. 07	MT
Baird Adjusts Price Target on Waters to $374 From $355, Maintains Outperform Rating	May. 07	MT
JPMorgan Adjusts Price Target on Waters to $350 From $390, Maintains Neutral Rating	May. 07	MT
Leerink Partners Raises Price Target on Waters to $450 From $400, Keeps Outperform Rating	May. 06	MT
Nephron Research Adjusts Waters Price Target to $425 From $440	May. 06	MT
Evercore ISI Adjusts Waters Price Target to $360 From $380	May. 06	MT
Waters Corporation to Seek M&A	May. 06	CI
Waters Corporation, Q1 2025 Earnings Call, May 06, 2025	May. 06
Waters raises 2025 profit forecast on resilient demand for lab equipment	May. 06	RE
Tranche Update on Waters Corporation's Equity Buyback Plan announced on January 23, 2019.	May. 06	CI
Waters Q1 Non-GAAP Earnings, Revenue Increase; 2025 Guidance Raised	May. 06	MT
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Revenue $661.7M, vs. FactSet Est of $642.0M	May. 06	MT
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Adjusted EPS $2.25, vs. FactSet Est of $2.22	May. 06	MT

Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (64.4%): chromatographic analysis instruments (58.3% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.5%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (13.2%); - services (35.6%): support services, training, etc. Net sales are distributed by market between pharmaceutical (57.4%), industrial (30.7%), academic institutions and governmental agencies (11.9%). Net sales are distributed geographically as follows: the United States (31.4%), Americas (6.1%), China (14.9%), Japan (5.7%), Asia (13.5%) and Europe (28.4%).

Employees

7,600

Sector

Advanced Medical Equipment & Technology

Calendar

Aug. 04 - Q2 2025 Earnings Release (Projected)

More about the company